메뉴 건너뛰기




Volumn 5, Issue , 2005, Pages

Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: Does interferon therapy prevent osteoporosis?

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; LAMIVUDINE; OSTEOCALCIN; PARATHYROID HORMONE; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR ALPHA; ALPHA INTERFERON; ANTIVIRUS AGENT; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; INTERLEUKIN DERIVATIVE; PEPTIDE; RECOMBINANT PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EID: 26444569263     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-5-30     Document Type: Article
Times cited : (15)

References (49)
  • 1
    • 0042567226 scopus 로고    scopus 로고
    • Osteoporosis in pediatrics
    • Hartman C, Hochberg Z, Shamir R: Osteoporosis in pediatrics. IMAJ 2003, 5: 509-515.
    • (2003) IMAJ , vol.5 , pp. 509-515
    • Hartman, C.1    Hochberg, Z.2    Shamir, R.3
  • 3
    • 0029989903 scopus 로고    scopus 로고
    • Osteodystrophy in patients with chronic hepatitis and liver cirrhosis
    • Tsuneoka K, Tameda Y, Takase K, Nakano T: Osteodystrophy in patients with chronic hepatitis and liver cirrhosis. J Gastroenterol 1996,31: 669-678.
    • (1996) J. Gastroenterol. , vol.31 , pp. 669-678
    • Tsuneoka, K.1    Tameda, Y.2    Takase, K.3    Nakano, T.4
  • 5
    • 0028925088 scopus 로고
    • Bone marrow, cytokines and bone remodelling. Emerging insights into the pathophysiology of osteoporosis
    • Manolagas SCV, Jilka RL: Bone marrow, cytokines and bone remodelling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995, 332: 305-311.
    • (1995) N. Engl. J. Med. , vol.332 , pp. 305-311
    • Manolagas, S.C.V.1    Jilka, R.L.2
  • 7
    • 0035173305 scopus 로고    scopus 로고
    • Osteodystrophy in posthepatic cirrhosis. in posthepatic cirrhosis
    • Karan MA, Erten N, Tascioglu C, Karan A, Sindel D, Dilsen G: Osteodystrophy in posthepatic cirrhosis. in posthepatic cirrhosis. YMJ 2001, 42: 547-552.
    • (2001) YMJ , vol.42 , pp. 547-552
    • Karan, M.A.1    Erten, N.2    Tascioglu, C.3    Karan, A.4    Sindel, D.5    Dilsen, G.6
  • 12
    • 0027236839 scopus 로고
    • Role of cytokines in the regulation of bone resorption
    • Roodman GD: Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 1993, 53: 94-98.
    • (1993) Calcif. Tissue Int. , vol.53 , pp. 94-98
    • Roodman, G.D.1
  • 13
    • 0343554631 scopus 로고    scopus 로고
    • Does the secretion of cytokines in the periphery reflect their role in bone metabolic diseases?
    • Natale VM, Filho WJ, Duarte AJS: Does the secretion of cytokines in the periphery reflect their role in bone metabolic diseases? Mech Ageing Dev 1997, 94: 14-23.
    • (1997) Mech. Ageing Dev. , vol.94 , pp. 14-23
    • Natale, V.M.1    Filho, W.J.2    Duarte, A.J.S.3
  • 15
    • 0036041033 scopus 로고    scopus 로고
    • Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy
    • Gur A, Denli A, Nas K, Cevik R, Karakoc M, Sarac Aj, ERdogan F: Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy. Rheumatol Int 2002,22: 194-198.
    • (2002) Rheumatol. Int. , vol.22 , pp. 194-198
    • Gur, A.1    Denli, A.2    Nas, K.3    Cevik, R.4    Karakoc, M.5    Sarac, Aj.6    ERdogan, F.7
  • 16
    • 0037296799 scopus 로고    scopus 로고
    • The effects of alendronate and calcitonin on cytokines in postmenopausal osteoporosis: A randomized and controlled study
    • Gur A, Denli A, Cevik R, Nas K, Karakoc M, Sarac AJ: The effects of alendronate and calcitonin on cytokines in postmenopausal osteoporosis: a randomized and controlled study. YMJ 2003, 44: 99-109.
    • (2003) YMJ , vol.44 , pp. 99-109
    • Gur, A.1    Denli, A.2    Cevik, R.3    Nas, K.4    Karakoc, M.5    Sarac, A.J.6
  • 17
    • 0033038734 scopus 로고    scopus 로고
    • The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence
    • Hirano Y, Kishimoto H, Hagino H, Teshima R: The change of bone mineral density in secondary osteoporosis and vertebral fracture incidence. JBMM 1999, 17: 119-124.
    • (1999) JBMM , vol.17 , pp. 119-124
    • Hirano, Y.1    Kishimoto, H.2    Hagino, H.3    Teshima, R.4
  • 18
    • 0028478015 scopus 로고
    • Osteoporosis in chronic liver disease: Pathogenesis, risk factors, and management
    • McGaughan GW, Feller RB: Osteoporosis in chronic liver disease: Pathogenesis, risk factors, and management. Dig Dis 1994, 12: 223-231.
    • (1994) Dig. Dis. , vol.12 , pp. 223-231
    • McGaughan, G.W.1    Feller, R.B.2
  • 19
    • 0027278259 scopus 로고
    • Bone disease in liver transplant recipients
    • Hay JE: Bone disease in liver transplant recipients. Gastroenterol Clin North Am 1993, 22: 237-249.
    • (1993) Gastroenterol. Clin. North Am. , vol.22 , pp. 237-249
    • Hay, J.E.1
  • 20
    • 0028832930 scopus 로고    scopus 로고
    • Primary biliary cirrhosis and bone disease
    • Rosen H: Primary biliary cirrhosis and bone disease. Hepatology 1996, 21: 253-255.
    • (1996) Hepatology , vol.21 , pp. 253-255
    • Rosen, H.1
  • 21
    • 0023138064 scopus 로고
    • Low bone turnover state in primary biliary cirrhosis
    • Stellon AJ, Webb A, Compston J, Williams R: Low bone turnover state in primary biliary cirrhosis. Hepatology 1987, 7: 137-142.
    • (1987) Hepatology , vol.7 , pp. 137-142
    • Stellon, A.J.1    Webb, A.2    Compston, J.3    Williams, R.4
  • 25
    • 0033834502 scopus 로고    scopus 로고
    • Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation
    • Trautwein C, Possienke M, Schlitt H, Boker KH, Horn R, Raab R, Manns MP, Brabant G: Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 2000, 95: 2343-2351.
    • (2000) Am. J. Gastroenterol. , vol.95 , pp. 2343-2351
    • Trautwein, C.1    Possienke, M.2    Schlitt, H.3    Boker, K.H.4    Horn, R.5    Raab, R.6    Manns, M.P.7    Brabant, G.8
  • 26
    • 0023925990 scopus 로고
    • Therapeutic strategies for hepatic fibrosis
    • Chojkier M, Brenner DA: Therapeutic strategies for hepatic fibrosis. Hepatology 1988, 8: 176-182.
    • (1988) Hepatology , vol.8 , pp. 176-182
    • Chojkier, M.1    Brenner, D.A.2
  • 27
    • 0024516970 scopus 로고
    • Differential effects of interleukin-1 alpha, tumor necrosis factor alpha and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat storing cells
    • Matsuoka M, Pham NT, Tsukamoto H: Differential effects of interleukin-1 alpha, tumor necrosis factor alpha and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat storing cells. Liver 1989, 9: 71-78.
    • (1989) Liver , vol.9 , pp. 71-78
    • Matsuoka, M.1    Pham, N.T.2    Tsukamoto, H.3
  • 28
    • 0023907136 scopus 로고
    • Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis
    • Stellon AJ, Webb A, Compston JE: Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988, 29: 378-384.
    • (1988) Gut , vol.29 , pp. 378-384
    • Stellon, A.J.1    Webb, A.2    Compston, J.E.3
  • 33
    • 17144399925 scopus 로고    scopus 로고
    • Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection
    • Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Mossner J, Caca K: Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 2005, 11: 1843-1847.
    • (2005) World J. Gastroenterol. , vol.11 , pp. 1843-1847
    • Schiefke, I.1    Fach, A.2    Wiedmann, M.3    Aretin, A.V.4    Schenker, E.5    Borte, G.6    Mossner, J.7    Caca, K.8
  • 36
    • 0028111183 scopus 로고
    • Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
    • Garnero P, Gineyts E, Riou JP, Delmas PD: Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994, 79: 780-785.
    • (1994) J. Clin. Endocrinol. Metab. , vol.79 , pp. 780-785
    • Garnero, P.1    Gineyts, E.2    Riou, J.P.3    Delmas, P.D.4
  • 41
    • 0020540586 scopus 로고
    • Hepatic osteodystrophy in primary biliary cirrhosis, a possible defect in Kuppfer cell cleavage of parathyroid hormone
    • Atkinson MJ, Vido I, Keck E, Hesch RD: Hepatic osteodystrophy in primary biliary cirrhosis, a possible defect in Kuppfer cell cleavage of parathyroid hormone. Clin Endocrinol (Oxf) 1983, 18: 21-28.
    • (1983) Clin. Endocrinol. (Oxf.) , vol.18 , pp. 21-28
    • Atkinson, M.J.1    Vido, I.2    Keck, E.3    Hesch, R.D.4
  • 43
    • 0028067822 scopus 로고
    • Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist
    • Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C: Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist. Blood 1994, 84: 4142-4150.
    • (1994) Blood , vol.84 , pp. 4142-4150
    • Aman, M.J.1    Keller, U.2    Derigs, G.3    Mohamadzadeh, M.4    Huber, C.5    Peschel, C.6
  • 44
    • 0024602819 scopus 로고
    • Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro
    • Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD: Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 1989, 4: 113-118.
    • (1989) J. Bone Miner. Res. , vol.4 , pp. 113-118
    • Pfeilschifter, J.1    Chenu, C.2    Bird, A.3    Mundy, G.R.4    Roodman, G.D.5
  • 45
    • 0034735773 scopus 로고    scopus 로고
    • T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-g
    • Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A: T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-g. Nature 2000, 408: 600-605.
    • (2000) Nature , vol.408 , pp. 600-605
    • Takayanagi, H.1    Ogasawara, K.2    Hida, S.3    Chiba, T.4    Murata, S.5    Sato, K.6    Takaoka, A.7
  • 46
    • 0033758693 scopus 로고    scopus 로고
    • Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C
    • Solis-Herruzo JA, Castellano G, Fernandez I, Munoz R, Hawkins F: Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C. J Hepatol 2000, 33: 812-817.
    • (2000) J. Hepatol. , vol.33 , pp. 812-817
    • Solis-Herruzo, J.A.1    Castellano, G.2    Fernandez, I.3    Munoz, R.4    Hawkins, F.5
  • 49
    • 0025012431 scopus 로고
    • Intereferons-alpha and -gamma inhibit interleukin-1b-stimulated osteoclast-like cell formation in long- term human marrow cultures
    • Kurihara N, Roodman GD: Intereferons-alpha and -gamma inhibit interleukin-1b-stimulated osteoclast-like cell formation in long- term human marrow cultures. J Interferon Res 1990, 10: 541-547.
    • (1990) J. Interferon. Res. , vol.10 , pp. 541-547
    • Kurihara, N.1    Roodman, G.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.